课题基金 / 基金详情

THALIDOMIDE FOR TREATMENT OF ORAL/ESOPHAGEAL APHTHYOUS ULCERS AND HIV VIREMIA

THALIDOMIDE FOR TREATMENT OF ORAL/ESOPHAGEAL APHTHYOUS ULCERS AND HIV VIREMIA
沙利度胺用于治疗口腔/食管口疮溃疡和 HIV 病毒血症
批准号：
6117759
负责人：
JOSEPH WHEAT
金额：
$1.7万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117759
关键词：
HIV infections aphthous stomatitis clinical research drug screening /evaluation esophagus disorder gastrointestinal disorder chemotherapy human subject human therapy evaluation oral pharyngeal disorder placebos thalidomide

项目摘要

项目成果

JOSEPH WHEAT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will employ a multi-center, phase II/III, double-blind randomized, placebo-controlled design. Patients with HIV infection and oral and/or esophageal aphthous ulcers of more than two weeks duration will be entered. Patients will be randomized to receive a 4 week course of either 200 mg thalidomide or placebo orally once daily.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DAPSONE AND ATOVAQUONE FOR PROPHYLAXIS AGAINST PCP
AMBISOME VS AMPHOTERICIN B FOLLOWED BY FLUCONAZOLE IN TREATMENT OF MENINGITIS
CS96 209 SCH56592 VERSUS FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDA
PHASE II TRIAL OF MEGESTROL ACETATE AND TESTOSTERONE
海外基金